CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial–mesenchymal transition in tumor microenvironment
Cancer Science · 2024
DOI: 10.1111/cas.16045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Kazuki Takahashi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Hauptthemen laut MEDLINE: Endothelial Cells, Endothelial-Mesenchymal Transition. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cooperation Program between TMDU, Sony Corporation and Sony Group Corporation, Japan Agency for Medical Research and Development, Japan Science and Technology Corporation.
Abstract (Originalsprache)
Tumor progression and metastasis are regulated by endothelial cells undergoing endothelial–mesenchymal transition (EndoMT), a cellular differentiation process in which endothelial cells lose their properties and differentiate into mesenchymal cells. The cells undergoing EndoMT differentiate through a spectrum of intermediate phases, suggesting that some cells remain in a partial EndoMT state and exhibit an endothelial/mesenchymal phenotype. However, detailed analysis of partial EndoMT has been hampered by the lack of specific markers. Transforming growth factor‐β (TGF‐β) plays a central role in the induction of EndoMT. Here, we showed that inhibition of TGF‐β signaling suppressed EndoMT in a human oral cancer cell xenograft mouse model. By using genetic labeling of endothelial cell lineage, we also established a novel EndoMT reporter cell system, the EndoMT reporter endothelial cells (EMRECs), which allow visualization of sequential changes during TGF‐β‐induced EndoMT. Using EMRECs, we characterized the gene profiles of multiple EndoMT stages and identified CD40 as a novel partial EndoMT‐specific marker. CD40 expression was upregulated in the cells undergoing partial EndoMT, but decreased in the full EndoMT cells. Furthermore, single‐cell RNA sequencing analysis of human tumors revealed that CD40 expression was enriched in the population of cells expressing both endothelial and mesenchymal cell markers. Moreover, decreased expression of CD40 in EMRECs enhanced TGF‐β‐induced EndoMT, suggesting that CD40 expressed during partial EndoMT inhibits transition to full EndoMT. The present findings provide a better understanding of the mechanisms underlying TGF‐β‐induced EndoMT and will facilitate the development of novel therapeutic strategies targeting EndoMT‐driven cancer progression and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
- Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.
- Department of Oral and Maxillofacial Surgical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
- Department of Biostatistics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
- Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
- Scientific Affairs Section, Life Science Sales Department, Life Science Business Division, Medical Business Group, Sony Corporation, Kanagawa, Japan.
ORCID-Profile: Miho Kobayashi, Fumiko Itoh, Katarzyna A Podyma-Inoue, Tetsuro Watabe
Förderung
- Cooperation Program between TMDU, Sony Corporation and Sony Group Corporation
- Japan Agency for Medical Research and Development
- Japan Science and Technology Corporation
- Japan Society for the Promotion of Science
- Nanken-Kyoten, TMDU
Zitieren
APA
Takahashi, K., Kobayashi, M., Katsumata, H., Tokizaki, S., Anzai, T., Ikeda, Y., Alcaide, D. M., Maeda, K., Ishihara, M., Tahara, K., Kubota, Y., Itoh, F., Park, J., Takahashi, K., Matsunaga, Y. T., Yoshimatsu, Y., Podyma-Inoue, K. A., & Watabe, T. (2024). CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial–mesenchymal transition in tumor microenvironment. Cancer Science. https://doi.org/10.1111/cas.16045
Vancouver
Takahashi K, Kobayashi M, Katsumata H, Tokizaki S, Anzai T, Ikeda Y, et al. CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial–mesenchymal transition in tumor microenvironment. Cancer Science. 2024. doi:10.1111/cas.16045
BibTeX
@article{Takahashi2024,
author = {Takahashi, Kazuki and Kobayashi, Miho and Katsumata, Hisae and Tokizaki, Shiori and Anzai, Tatsuhiko and Ikeda, Yukinori and Alcaide, Daniel M and Maeda, Kentaro and Ishihara, Makoto and Tahara, Katsutoshi and Kubota, Yoshiaki and Itoh, Fumiko and Park, Jihwan and Takahashi, Kunihiko and Matsunaga, Yukiko T and Yoshimatsu, Yasuhiro and Podyma-Inoue, Katarzyna A and Watabe, Tetsuro},
title = {CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial–mesenchymal transition in tumor microenvironment},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16045}
}
EUVIMED